Abstract
Yen E, Davis JM, Milne CP. Impact of regulatory incentive programs on the future of pediatric drug development. Therapeutic Innovation & Regulatory Science 2019;53(5):609-614. https://doi.org/10.1177/2168479019837522
In this article, the funding information was not disclosed, as given below:
Footnotes
Funding
The original study by Tufts CSDD in 2016 was funded in part by a grant from PhRMA (Pharmaceutical Research and Manufacturers of America).